InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Saxena Nishant C. Director active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Cumulatively, 2 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €22k. History available since 21 May 2026. The latest transaction was disclosed on 11 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations